全文获取类型
收费全文 | 5171篇 |
免费 | 439篇 |
国内免费 | 116篇 |
专业分类
耳鼻咽喉 | 46篇 |
儿科学 | 163篇 |
妇产科学 | 112篇 |
基础医学 | 740篇 |
口腔科学 | 122篇 |
临床医学 | 533篇 |
内科学 | 953篇 |
皮肤病学 | 44篇 |
神经病学 | 453篇 |
特种医学 | 286篇 |
外科学 | 967篇 |
综合类 | 136篇 |
一般理论 | 2篇 |
预防医学 | 415篇 |
眼科学 | 50篇 |
药学 | 308篇 |
中国医学 | 6篇 |
肿瘤学 | 390篇 |
出版年
2023年 | 21篇 |
2022年 | 45篇 |
2021年 | 105篇 |
2020年 | 62篇 |
2019年 | 108篇 |
2018年 | 124篇 |
2017年 | 86篇 |
2016年 | 107篇 |
2015年 | 111篇 |
2014年 | 149篇 |
2013年 | 240篇 |
2012年 | 323篇 |
2011年 | 325篇 |
2010年 | 176篇 |
2009年 | 169篇 |
2008年 | 255篇 |
2007年 | 319篇 |
2006年 | 211篇 |
2005年 | 223篇 |
2004年 | 200篇 |
2003年 | 157篇 |
2002年 | 175篇 |
2001年 | 141篇 |
2000年 | 144篇 |
1999年 | 127篇 |
1998年 | 84篇 |
1997年 | 79篇 |
1996年 | 72篇 |
1995年 | 68篇 |
1994年 | 59篇 |
1993年 | 38篇 |
1992年 | 106篇 |
1991年 | 85篇 |
1990年 | 121篇 |
1989年 | 105篇 |
1988年 | 87篇 |
1987年 | 83篇 |
1986年 | 89篇 |
1985年 | 65篇 |
1984年 | 54篇 |
1983年 | 39篇 |
1982年 | 28篇 |
1981年 | 30篇 |
1979年 | 41篇 |
1978年 | 28篇 |
1977年 | 24篇 |
1976年 | 24篇 |
1975年 | 20篇 |
1974年 | 31篇 |
1971年 | 19篇 |
排序方式: 共有5726条查询结果,搜索用时 437 毫秒
991.
992.
A rapid and efficient immunization protocol for production of monoclonal antibodies reactive with autoantigens 总被引:8,自引:0,他引:8
A simple, time-saving and efficient immunization method suitable for the production of mouse monoclonal antibody secreting hybridomas is described. Draining lymph nodes isolated 9 days after a primary immunization were used as the source of antibody producing cells. No systemic spread of antibody producing cells or specific antibodies could be detected. The present protocol was employed to generate a panel of collagen type II reactive monoclonal antibodies. Most of the monoclonals so generated were found to be of the IgG class. 相似文献
993.
A new mdr-1 encoded P-170 specific monoclonal antibody: (6/1C) on paraffin wax embedded tissue without pretreatment of sections. 下载免费PDF全文
E Moran A Larkin G Doherty P Kelehan S Kennedy M Clynes 《Journal of clinical pathology》1997,50(6):465-471
AIMS: The generation and characterisation of a monoclonal antibody that specifically recognises the mdr-1 encoded protein, P-glycoprotein (P-170), on routinely processed formalin fixed, paraffin wax embedded tissue sections. METHODS: The monoclonal antibody, designated 6/1C, was produced following a combination of in vivo and in vitro immunisation regimens in Balb/c mice with a synthetic 12 amino acid peptide that corresponds to amino acids 21-32 (believed to be intracellularly located) of P-170 and has insignificant homology with the mdr-3 encoded P-170. Antibody 6/1C was characterised by western blotting and immunocytochemistry on cytospins of paired multidrug resistant or sensitive cell lines, including mdr-1 and mdr-3 transfected cells, and by immunohistochemistry on normal and malignant formalin fixed paraffin wax embedded tissue sections. RESULTS: Antibody 6/1C showed a single band at 170 kDa on western blots of multidrug resistant cell lysates and mdr-1 transfected cell lysates that was absent on similar preparations of drug sensitive cells and mdr-3 transfected cells. Immunocytochemical studies on cytospins of multidrug resistant cells and mdr-1 transfected cells revealed strong inner plasma membrane/cytoplasmic staining. Staining was negligible on drug sensitive cells and cells transfected with the mdr-3 gene. Immunohistochemical studies on formalin fixed, paraffin wax embedded normal adult kidney, liver, and breast tissue and a range of fetal tissues exhibited staining patterns of a variety of secretory surfaces consistent with documented mdr-1 specific staining. Specific staining of malignant cells in similarly treated sections of breast tumours was seen also with antibody 6/1C. Staining on paraffin wax embedded tissue with this antibody did not require any pretreatment of tissue sections. CONCLUSIONS: This new monoclonal antibody, chosen for its specificity with the mdr-1 encoded P-170 and its reactivity on routinely fixed paraffin wax embedded tissue samples without pretreatment, appears to be useful for the investigation of P-170 in archival material. It is especially useful for retrospective studies on pretreatment and post-treatment tissue sections, and could help establish when and how rapidly mdr-1 associated drug resistance develops during chemotherapeutic regimens. Immunohistochemical assessment of P-170 expression in many cancers has potential for diagnostic purposes and may influence the choice of chemotherapeutic drugs used in the treatment of refractory tumours. 相似文献
994.
Lovatt A Black J Galbraith D Doherty I Moran MW Shepherd AJ Griffen A Bailey A Wilson N Smith KT 《Journal of virological methods》1999,82(2):185-200
The development and application of a novel, sensitive TaqMan fluorescent probe-based product enhanced RT test (F-PERT) for the detection of retrovirus are described. The assay allows discrimination between the amplification signals generated by genuine positive signals that result from retroviral RT activity and the RT-like activity from DNA polymerases. The RT-like activity from DNA polymerases was suppressed by the addition of activated calf-thymus DNA with no reduction in the RT activity. A linear relationship between threshold cycle (C(T)) and the number of virus particles was demonstrated, allowing quantification of retroviruses in unknown samples. The F-PERT assay was able to detect a wide range of retroviral RT activities, including that from porcine endogenous retrovirus (PoERV), murine leukaemia virus (MLV), simian foamy virus (SFV), simian immunodeficiency virus (SIVmac) and squirrel monkey retrovirus (SMRV). The detection limit of SMRV, MLV and PoERV was approximately 100 virion particles and the test was able to detect at least 10(2) molecules of purified RT enzyme. RT activity was not detected in cellular lysates and supernatants from MRC-5, BT, VERO, or Raji cells, whereas RT activity was detected in C1271, Mus dunni, K-Balb, BHK-21, CHO-K1, SP2/0-Ag14 and NSO cell supernatants. RT activity was also detected in the Spodoptera cell line Sf9. 相似文献
995.
Ruth Burstein Ariel Hourvitz Yoram Epstein Zeev Dvir Daniel Moran Jacob Altar Joshua Shemer Arie Shalev Eithan Galun 《European journal of applied physiology》1993,66(4):372-375
Summary Antibiotic treatment tends sometimes to result in sensations of fatigue and decreased physical performance. The effects of antibiotics were therefore studied in 50 healthy, male trainees, aged 18–25 years, assigned in a random, double-blind fashion to one of the following treatments: tetracycline, ampicillin, trimethoprim/sulphamethoxazole, placebo I and placebo II. Duration of treatment was five times the half-life of each agent and the placebo was matched accordingly. Muscle enzyme activity (serum glutamine oxaloacetate transaminase, lactate dehydrogenase, creatine phosphokinase), maximal aerobic capacity (
O2max), muscle strength (MS), and rating of subjective sensation of fatigue were assessed prior to and upon conclusion of treatment. Compared to pretreatment values, plasma enzymes activity was elevated in all five groups (P<0.005). No differences in
O2max or in MS were found among the subjects treated with either one of the antibiotics or those given a placebo. A significant difference in
O2max was found between the groups treated for 1 day (antibiotic and placebo) and the groups treated for 3 days (antibiotic and placebo) (P<0.0001). The rating of subjective sensation was not affected by any of the agents. We concluded that in healthy individuals, a short-term antibiotic treatment had no deleterious effect on aerobic capacity or on muscle strength and was not associated with subjective side effects. The time interval between the two maximal tests could, however, have affected the aerobic capacity. Physiological disturbances associated with a sensation of fatigue following a longer period of antibiotics cannot be excluded. 相似文献
996.
997.
Clinical and in vitro studies have implicated dietary components as major aetiological factors in staining of teeth and acrylic materials associated with chlorhexidine use, a local side effect not unique to this antiseptic. These experiments studied the precipitation and surface staining reactions of the cationic antiseptics alexidine, cetyl pyridinium chloride (CPC), chlorhexidine, and hexetidine, with the beverage tea. All of the antiseptics precipitated a standard tea solution and for alexidine and chlorhexidine acetate and gluconate, this was at concentrations greater than 100 mumol/L, for hexetidine greater than 200 mumol/L, and for CPC greater than 400 mumol/L. With the exception of CPC precipitation was reduced with decreasing pH and for chlorhexidine was inhibited below pH 3. The addition of polymethylmethacrylate (PMMA) to the antiseptic solutions increased the precipitation concentrations by an amount calculated to be adsorbed by polymer. Acrylic blocks treated with equimolar solutions of the antiseptics became progressively and significantly more stained by tea than control specimens over a 5-day period. Alexidine induced significantly greater staining and hexetidine significantly less than the other antiseptics. Staining was pH dependent and significantly reduced as the pH decreased. Both stain and precipitates were insoluble in strong acids and alkalis. It is concluded that staining observed clinically may represent a precipitation reaction with the complexing of antiseptics with dietary chromogenic material. 相似文献
998.
Sitagliptin Treatment After Total Pancreatectomy With Islet Autotransplantation: A Randomized,Placebo‐Controlled Study 下载免费PDF全文
M. D. Bellin G. J. Beilman T. B. Dunn T. L. Pruett D. E. R. Sutherland S. Chinnakotla J. S. Hodges A. Lane P. Ptacek K. L. Berry B. J. Hering A. Moran 《American journal of transplantation》2017,17(2):443-450
Insulin independence after total pancreatectomy and islet autotransplant (TPIAT) for chronic pancreatitis is limited by a high rate of postprocedure beta cell apoptosis. Endogenous glucagon‐like peptide‐1 and glucose‐dependent insulinotropic peptide, which are increased by dipeptidyl peptidase 4 inhibitor therapy (sitagliptin) may protect against beta cell apoptosis. To determine the effect of sitagliptin after TPIAT, 83 adult TPIAT recipients were randomized to receive sitagliptin (n = 54) or placebo (n = 29) for 12 months after TPIAT. At 12 and 18 months after TPIAT, participants were assessed for insulin independence; metabolic testing was performed with mixed meal tolerance testing and frequent sample intravenous glucose tolerance testing. Insulin independence did not differ between the sitagliptin and placebo groups at 12 months (42% vs. 45%, p = 0.82) or 18 months (36% vs. 44%, p = 0.48). At 12 months, insulin dose was 9.0 (standard error 1.7) units/day and 7.9 (2.2) units/day in the sitagliptin and placebo groups, respectively (p = 0.67) and at 18 months 10.3 (1.9) and 7.1 (2.6) units/day, respectively (p = 0.32). Hemoglobin A1c levels and insulin secretory measures were similar in the two groups, as were adverse events. In conclusion, sitagliptin could be safely administered but did not improve metabolic outcomes after TPIAT. 相似文献
999.